Tunde Csepany
Tunde Csepany is an expert in Neurology at University of Debrecen (Hungary). Tunde Csepany has authored 107 publications, the most recent in 2026. SLR score: 199 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Immunology - Neurosurgery - Psychiatry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1980 - 2026
Number : 107
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis. PMID 42496160 — sclerosis, multiple sclerosis, incidence, therapeutics, wounds and injuries, neurology, multiple sclerosis, relapsing-remitting | Brain | 2026 | 0 |
| Causal effects of multiple sclerosis therapies in left-truncated registry data. PMID 42479470 — registries, sclerosis, multiple sclerosis, bias, demyelinating diseases, therapeutics | Mult Scler | 2026 | 0 |
| Predicting disease progression in multiple sclerosis with clinically accessible information and technology. PMID 42002655 — sclerosis, multiple sclerosis, bias, disease progression, neurosurgery, therapeutics, learning, neurology | J Neurol | 2026 | 0 |
| Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry. PMID 41634506 — registries, sclerosis, multiple sclerosis, phenotype, multiple chronic conditions, neurosurgery, neurology | J Neurol | 2026 | 0 |
| Managing reactivation of multiple sclerosis during treatment with natalizumab. PMID 41420376 — sclerosis, multiple sclerosis, natalizumab, central nervous system diseases, alemtuzumab, treatment failure, therapeutics | Mult Scler | 2025 | 0 |
LeadR Networks
Main global connection map